Clinical Trial Update: Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137) [Phase 3]

View source ↗

Summary

Phase 3 trial BY9010/M1-137 comparing the efficacy of ciclesonide versus budesonide in adults with asthma has completed. The update summarizes the trial outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (BUDESONIDE)
• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED